Accueil   Diary - News   All news ERYTECH wins the european small and mid-cap award

ERYTECH wins the european small and mid-cap award

ERYTECH Wins the european small and mid-cap award in the most innovative newcomer catergory

 

Lyon (France), December 10, 2015– ERYTECH Pharma (Euronext Paris: ERYP & OTC US: EYRYY),the French biopharmaceutical company that develops innovative ‘tumor starvation’ treatments for acute leukemia and other malignancies with unmet medical needs, announced today that it received yesterday evening the “European Small and Mid-Cap” award in the “Most Innovative Newcomer” category  by the Federation of European Stock Exchanges. 

 

Read the press release